Profile
AMIX ABT BSX-PA BSX SYK MDT
Company Name Autonomix Medical, Inc. Common Stock Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $6.28M $232.02B $175.45B $144.14B $141.53B $123.78B
Employees 0.01K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Bradley Hauser Robert B. Ford Michael F. Mahoney Michael F. Mahoney Kevin A. Lobo Geoffrey Straub Martha
Ratings
AMIX ABT BSX-PA BSX SYK MDT
Quant Rating Score 2 4 3 3 3
Quant Rating Sell Buy Neutral Neutral Neutral
Trading
AMIX ABT BSX-PA BSX SYK MDT
Last Close $1.26 $133.31 $122.18 $97.28 $370.2 $96.5
High 52 $14.31 $140.22 $122.18 $108.14 $403.53 $98.43
Low 52 $0.49 $111.1 $122.18 $83.62 $337.28 $79.61
Price vs. 52 Week High -91.19 % -4.93 % 0 % -10.04 % -8.26 % -1.96 %
Price vs. 52 Week Low 157.14 % 19.99 % 0 % 16.34 % 9.76 % 21.22 %
Total Return
AMIX ABT BSX-PA BSX SYK MDT
1 Month Return 8.62 % 3.05 % 0 % -7.55 % -3.33 % 4.53 %
3 Month Return -16.56 % -0.22 % 0 % -6.34 % -6.22 % 7.94 %
6 Month Return -23.17 % 7.08 % 0 % 5.01 % 6.26 % 16.91 %
9 Month Return -56.4 % 18.7 % 0 % 2.53 % 1.24 % 19.64 %
YTD Return -66.49 % 17.86 % 0 % 8.91 % 2.82 % 20.81 %
1 Year Return 114.61 % 15.3 % 0 % 12.85 % 4.76 % 8.61 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AMIX ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.74 % - - 0.91 % 2.92 %
Dividend Paid and Capex Coverage Ration (TTM) -1001.11 % 1.45 % 4.3 % 4.3 % 2.39 % 1.31 %
Dividend Per Share (TTM) - 2.32 % - - 3.36 % 2.82 %
Payout Ratio (TTM) - 28.42 % 0.92 % 0.92 % 42.87 % 77.26 %
Growth
AMIX ABT BSX-PA BSX SYK MDT
Asset Growth 4.24 % 11.2 % 12.12 % 12.12 % 1.89 %
Gross Profit Growth -125.93 % 6.43 % 16.26 % 16.26 % 3.58 %
Revenue Growth - 4.59 % 17.61 % 17.61 % 3.62 %
Revenue 3 Year - -0.18 % 36.16 % 36.16 % 10.52 %
Revenue 5 Year - 34.24 % 47.52 % 47.52 % 20.96 %
Revenue 10 Year - 80.43 % 104.22 % 104.22 % 41.05 %
EBIT Growth 26.8 % 3.45 % 18.25 % 18.25 % 14.42 %
Net Income Growth 26.03 % 134.18 % 16.38 % 16.38 % 26.82 %
Net Income 3 Yeari Growth Per Share -811 % 94.27 % 72.31 % 72.31 % -3.39 %
Net Income 5 Yeari Growth Per Share -811 % 271.11 % -62.7 % -62.7 % 1.52 %
Net Income 10 Yeari Growth Per Share -811 % 410.99 % 1502.13 % 1502.13 % 48.51 %
Operating Income Growth -55.04 % 6.06 % 20.82 % 20.82 % 15.77 %
Operating Cash Flow Growth (CFG) -24.22 % 17.86 % 37.24 % 37.24 % 3.79 %
Operating 3 Year CFG -22590.71 % -16.72 % 77.55 % 77.55 % 0.13 %
Operating 5 Year CFG -22590.71 % 42.4 % 76.92 % 76.92 % 1.55 %
Operating 10 Year CFG -22590.71 % 102.79 % 143.61 % 143.61 % 22.45 %
EPS Growth 69.38 % 132.42 % 16.61 % 16.61 % 31.05 %
EPS Diluted Growth 69.37 % 133.64 % 16.52 % 16.52 % 30.8 %
Book Value Per Share -56.05 % 23.54 % 11.25 % 11.25 % -1.16 %
Share Holder 3 Year Equity Growth Per Share 4298.59 % 36.46 % 26.58 % 26.58 % -4.58 %
Share Holder 5 Year Equity Growth Per Share 4298.59 % 56.53 % 48.35 % 48.35 % -1.29 %
Share Holder 10 Year Equity Growth Per Share 4298.59 % 92.83 % 186.31 % 186.31 % -23.12 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 1.11 %
Dividend 3 Year Growth Per Share - 22.8 % -100 % -100 % 10.78 %
Dividend 5 Year Growth Per Share - 72.53 % - - 29.33 %
Dividend 10 Year Growth Per Share - 148.92 % - - 128.74 %
Debt Growth -100 % -3.77 % 17.44 % 17.44 % 13.95 %
Free Cash Flow Growth -24.07 % 25.54 % 55.31 % 55.31 % -0.29 %
Updated On 31 Mar 2025 31 Dec 2024 31 Dec 2024 31 Dec 2024 25 Apr 2025
Profitability
AMIX ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM -60.47 % 52.79 % 63.23 % 63.23 % 62.19 % 63.44 %
Return on Assets TTM -133.9 % 16.64 % 6.02 % 6.02 % 6.3 % 5.12 %
Return on Equity TTM -172.93 % 29.93 % 11.49 % 11.49 % 14.08 % 9.62 %
Return on Capital Employed TTM -174.29 % 10.7 % 8.53 % 8.53 % 13.86 % 7.71 %
Net Income Per EBT TTM 100 % 176.99 % 83.43 % 83.43 % 87.08 % 82.32 %
EBT Per Ebit TTM 98.29 % 104.64 % 96.68 % 96.68 % 61.93 % 92.49 %
EBIT Per Revenue TTM -14251.16 % 17.51 % 16.77 % 16.77 % 22.72 % 17.9 %
Cash Flow To Debt Ratio TTM - 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Receivables Turnover TTM - 4.21 6.57 6.57 6.08 5.46
Payables Turnover TTM 0.12 4.73 7.07 7.07 6.25 4.89
Inventory Turnover TTM - 2.93 2.38 2.38 1.7 -33.52
Fixed Asset Turnover TTM 452.63 % 378.32 % 467.97 % 467.97 % 560.03 % -6785.71 %
Asset Turnover TTM 0.96 % 51.32 % 44.5 % 44.5 % 51.41 % 37.59 %
Operating Cash Flow Per Share TTM -2.9 5.19 2.9 2.9 12.47 5.58
Free Cash Flow Per Share TTM -2.9 3.89 2.24 2.24 10.53 4.14
Cash Per Share TTM 276.6 % 418.4 % 36.12 % 36.12 % 644.69 % 633.66 %
Operating Cash Flow Sales Ratio TTM -10476.74 % 20.96 % 23.17 % 23.17 % 20.01 % 20.89 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.1 % 74.97 % 77.27 % 77.27 % 84.43 % 74.21 %
Cash Flow Coverage Ratios TTM - 67.25 % 35.63 % 35.63 % 27.83 % 24.98 %
Price To Free Cash Flows Ratio TTM -0.7 34.25 43.54 43.54 35.17 23.34
Price To Operating Cash Flows Ratio TTM -0.42 25.67 33.57 33.57 29.69 17.31
Price Cash Flow Ratio TTM -0.42 25.67 33.57 33.57 29.69 17.31
Income Statement (TTM)
AMIX ABT BSX-PA BSX SYK MDT
Revenue $0B $41.95B $16.75B $16.75B $22.6B $33.54B
Gross Profit $-0B $21.33B $10.27B $10.27B $13.98B $21.91B
Gross Profit Ratio 0% 50.83% 61.31% 61.31% 61.87% 65.32%
EBITDA $-0.01B $10.83B $3.94B $3.94B $4.94B $9.22B
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.66B
EPS Diluted -6.46 7.64 1.25 1.25 7.76 3.61
Balance Sheet (MRQ)
AMIX ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $9.37B $9.37B $12.57B $25.64B
Total Liabilities $0B $33.51B $17.39B $17.39B $22.34B $43.42B
Total Equity $0.01B $47.9B $22B $22B $20.63B $48.26B
Total Investments $0B $1.24B $0.56B $0.56B $0.88B $6.75B
Total Debt $0B $15.28B $11.15B $11.15B $14.12B $28.52B
Total Assets $0.01B $81.41B $39.4B $39.4B $42.97B $91.68B
Cash Flow Statement (TTM)
AMIX ABT BSX-PA BSX SYK MDT
Net Income $-0.01B $13.4B $1.85B $1.85B $2.99B $4.69B
Inventory $0B $-0.06B $-0.23B $-0.23B $-0.21B $-0.29B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.59B
Operating Cash Flow $-0.01B $8.56B $3.44B $3.44B $4.24B $7.04B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.86B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 132.57
ADGM Adagio Medical Holdings, Inc. 2.02
AEMD Aethlon Medical, Inc. 0.6932
AFIB Acutus Medical, Inc. 0.0011
AHCO AdaptHealth Corp. 8.7
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 125.79
ALUR Allurion Technologies Inc. 2
ANIK Anika Therapeutics, Inc. 9.02
AORT Artivion, Inc. 40.2
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 2.97
ARAY Accuray Incorporated 1.77
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 13.14
AVNS Avanos Medical, Inc. 10.7
AVR Anteris Technologies Global Corp. Common Stock 4.61
AXDX Accelerate Diagnostics, Inc. 0.034
AXGN AxoGen, Inc. 15.99
ETFs With Exposure to AMIX
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 204.87
IWC iShares Micro-Cap ETF 0.00022 149.55
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 155.49
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 155.5
VEMPX Vanguard Extended Market Index InstlPlus 0 383.72
Unlock